Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-12 4:00 pm Sale |
2021-08-02 | 13D | Telesis Bio, Inc. TBIO |
Sanofi | 204,691 4.900% |
-66,667 (-24.57%) |
Filing History |
| 2021-03-31 11:19 am Purchase |
2021-03-25 | 13G | LAVA Therapeutics N.V. LVTX |
Sanofi | 1,919,455 7.000% |
1,919,455 (New Position) |
Filing History |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Sanofi SNY |
Amundi | 63,318,143 5.000% |
63,318,143 (New Position) |
Filing |
| 2021-02-11 10:46 am Purchase |
2020-02-13 | 13G | Fulcrum Therapeutics, Inc. FULC |
Sanofi | 3,363,050 4.600% |
3,363,050 (New Position) |
Filing History |
| 2021-02-04 06:57 am Purchase |
2020-07-20 | 13G | Telesis Bio, Inc. TBIO |
Sanofi | 271,357 6.600% |
271,357 (New Position) |
Filing History |
| 2021-02-01 08:17 am Purchase |
2020-12-31 | 13G | Sanofi SNY |
BlackRock Inc. BLK |
93,851,532 7.500% |
11,949,247 (+14.59%) |
Filing |